rs145976466

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_173630.4(RTTN):​c.6038G>T​(p.Cys2013Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00769 in 1,614,080 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C2013Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0054 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0079 ( 76 hom. )

Consequence

RTTN
NM_173630.4 missense

Scores

2
3
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.72

Publications

6 publications found
Variant links:
Genes affected
RTTN (HGNC:18654): (rotatin) This gene encodes a large protein whose specific function is unknown. Absence of the orthologous protein in mouse results in embryonic lethality with deficient axial rotation, abnormal differentiation of the neural tube, and randomized looping of the heart tube during development. In human, mutations in this gene are associated with polymicrogyria with seizures. In human fibroblasts this protein localizes at the ciliary basal bodies. Given the intracellular localization of this protein and the phenotypic effects of mutations, this gene is suspected of playing a role in the maintenance of normal ciliary structure which in turn effects the developmental process of left-right organ specification, axial rotation, and perhaps notochord development. [provided by RefSeq, Jan 2013]
RTTN Gene-Disease associations (from GenCC):
  • microcephalic primordial dwarfism due to RTTN deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • bilateral generalized polymicrogyria
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005443305).
BP6
Variant 18-70020730-C-A is Benign according to our data. Variant chr18-70020730-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130190.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0054 (822/152344) while in subpopulation NFE AF = 0.00839 (571/68034). AF 95% confidence interval is 0.00782. There are 4 homozygotes in GnomAd4. There are 406 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTTNNM_173630.4 linkc.6038G>T p.Cys2013Phe missense_variant Exon 45 of 49 ENST00000640769.2 NP_775901.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTTNENST00000640769.2 linkc.6038G>T p.Cys2013Phe missense_variant Exon 45 of 49 2 NM_173630.4 ENSP00000491507.1

Frequencies

GnomAD3 genomes
AF:
0.00540
AC:
822
AN:
152226
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00778
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00839
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00661
AC:
1646
AN:
248958
AF XY:
0.00741
show subpopulations
Gnomad AFR exome
AF:
0.00103
Gnomad AMR exome
AF:
0.00449
Gnomad ASJ exome
AF:
0.00537
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00837
Gnomad OTH exome
AF:
0.00711
GnomAD4 exome
AF:
0.00793
AC:
11587
AN:
1461736
Hom.:
76
Cov.:
31
AF XY:
0.00807
AC XY:
5869
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00170
AC:
57
AN:
33476
American (AMR)
AF:
0.00470
AC:
210
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00459
AC:
120
AN:
26130
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.0129
AC:
1112
AN:
86256
European-Finnish (FIN)
AF:
0.00185
AC:
99
AN:
53420
Middle Eastern (MID)
AF:
0.0206
AC:
119
AN:
5768
European-Non Finnish (NFE)
AF:
0.00851
AC:
9463
AN:
1111884
Other (OTH)
AF:
0.00671
AC:
405
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
575
1150
1726
2301
2876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00540
AC:
822
AN:
152344
Hom.:
4
Cov.:
32
AF XY:
0.00545
AC XY:
406
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00115
AC:
48
AN:
41572
American (AMR)
AF:
0.00771
AC:
118
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00705
AC:
34
AN:
4824
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00839
AC:
571
AN:
68034
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00724
Hom.:
19
Bravo
AF:
0.00535
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00129
AC:
5
ESP6500EA
AF:
0.00834
AC:
69
ExAC
AF:
0.00707
AC:
854
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00917
EpiControl
AF:
0.00806

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RTTN: BP4, BS1, BS2

Sep 20, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Aug 10, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 22, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Aug 18, 2025
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RTTN-related disorder Benign:1
Apr 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T;.;.
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.84
T;T;T
MetaRNN
Benign
0.0054
T;T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
1.9
M;.;M
PhyloP100
1.7
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.0
.;.;N
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;D
Sift4G
Pathogenic
0.0
.;.;D
Vest4
0.0
ClinPred
0.0078
T
GERP RS
6.1
Varity_R
0.13
gMVP
0.31
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145976466; hg19: chr18-67687966; COSMIC: COSV105050690; COSMIC: COSV105050690; API